Quick Answer
MUSTANG BIO, INC. reported Operating Income of -$2.43 million for fiscal year 2025.
MUSTANG BIO, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$2.43M | +85.0% |
| 2024 | -$16.25M | +67.0% |
| 2023 | -$49.26M | +35.3% |
| 2022 | -$76.16M | -14.1% |
| 2021 | -$66.72M | -17.5% |
| 2020 | -$56.81M | -23.8% |
| 2019 | -$45.88M | -47.0% |
| 2018 | -$31.22M | +1.8% |
| 2017 | -$31.79M | -179.7% |
| 2016 | -$11.36M | -402.8% |
| 2015 | -$2.26M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$624.0K | +57.2% | +29.5% |
| June 30, 2025 | -$885.0K | +89.6% | -249.8% |
| March 31, 2025 | -$253.0K | +95.2% | +82.6% |
| September 30, 2024 | -$1.46M | +85.9% | +82.9% |
| June 30, 2024 | -$8.54M | +38.5% | -63.3% |
| March 31, 2024 | -$5.23M | +67.9% | +49.2% |
| September 30, 2023 | -$10.31M | +45.3% | +25.8% |
| June 30, 2023 | -$13.89M | +23.8% | +14.9% |
- MUSTANG BIO, INC. showed an increase of +85.0% in Operating Income compared to the prior fiscal year.
- Over the 2015–2025 period, MUSTANG BIO, INC.’s operating income has declined by 7.6% (from -$2.26 million to -$2.43 million).
- The most recent figure is from MUSTANG BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: